These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25735325)

  • 1. Expression of glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis.
    Xiong XL; Qin H; Yan SQ; Zhou LS; Chen P; Zhao D
    Asian Pac J Cancer Prev; 2015; 16(3):1029-31. PubMed ID: 25735325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
    Yamauchi N; Watanabe A; Hishinuma M; Ohashi K; Midorikawa Y; Morishita Y; Niki T; Shibahara J; Mori M; Makuuchi M; Hippo Y; Kodama T; Iwanari H; Aburatani H; Fukayama M
    Mod Pathol; 2005 Dec; 18(12):1591-8. PubMed ID: 15920546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glypican 3 expression in pediatric malignant solid tumors.
    Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
    Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
    Wang FH; Wen JM; Vong HT; Yip YC
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
    Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
    Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution.
    Zhou S; Parham DM; Yung E; Pattengale P; Wang L
    Histopathology; 2015 Dec; 67(6):905-13. PubMed ID: 25939253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver.
    Levy M; Trivedi A; Zhang J; Miles L; Mattis AN; Kim GE; Lassman C; Anders RA; Misdraji J; Yerian LM; Xu H; Dhall D; Wang HL
    Hum Pathol; 2012 May; 43(5):695-701. PubMed ID: 21937079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal hepatic neoplasia in 3 children with APC gene mutation.
    Gupta A; Sheridan RM; Towbin A; Geller JI; Tiao G; Bove KE
    Am J Surg Pathol; 2013 Jul; 37(7):1058-66. PubMed ID: 23715166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3 expression in Wilms tumor and hepatoblastoma.
    Toretsky JA; Zitomersky NL; Eskenazi AE; Voigt RW; Strauch ED; Sun CC; Huber R; Meltzer SJ; Schlessinger D
    J Pediatr Hematol Oncol; 2001 Nov; 23(8):496-9. PubMed ID: 11878776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glypican 3 as a Serum Marker for Hepatoblastoma.
    Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
    Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J; Wei L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Glypican-3 Cleavage Results in Reduced Cell Proliferation in a Liver Cancer Cell Line.
    Schepers EJ; Lake C; Glaser K; Bondoc AJ
    J Surg Res; 2023 Feb; 282():118-128. PubMed ID: 36272230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.
    Ara T; Fukuzawa M; Oue T; Komoto Y; Kusafuka T; Imura K; Okada A
    J Pediatr Surg; 1997 Dec; 32(12):1690-4. PubMed ID: 9434000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
    Zhou F; Shang W; Yu X; Tian J
    Med Res Rev; 2018 Mar; 38(2):741-767. PubMed ID: 28621802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling.
    Midorikawa Y; Ishikawa S; Iwanari H; Imamura T; Sakamoto H; Miyazono K; Kodama T; Makuuchi M; Aburatani H
    Int J Cancer; 2003 Feb; 103(4):455-65. PubMed ID: 12478660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of glypican-3 immunohistochemistry in diagnosis of hepatocellular carcinoma].
    Yip YC; Wang FH; Vong HT; Zhang M; Wen JM
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):626-9. PubMed ID: 22177248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-3 expression predicts poor clinical outcome of patients with early-stage clear cell carcinoma of the ovary.
    Umezu T; Shibata K; Kajiyama H; Yamamoto E; Nawa A; Kikkawa F
    J Clin Pathol; 2010 Nov; 63(11):962-6. PubMed ID: 20972242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis.
    Sun B; Huang Z; Wang B; Yu Y; Lin S; Luo L; Wang Y; Huang Z
    Med Sci Monit; 2017 Feb; 23():850-855. PubMed ID: 28207681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Combined Glypican-3 and Glutamine Synthetase in Differential Diagnosis of Hepatocellular Lesions.
    Wasfy RE; Shams Eldeen AA
    Asian Pac J Cancer Prev; 2015; 16(11):4769-75. PubMed ID: 26107238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.